Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. Hims & Hers connects consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to primary care, mental health, sexual health, skincare, and more. Launched in November 2017, the platform also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers’ mission is to make it easier for all Americans to access affordable care and treatment for conditions that impact their daily lives. In January 2021, the company was listed on the NYSE at an initial valuation of $1.6 billion and is traded under the ticker symbol “HIMS”. To learn more about our brand and offerings, you can visit hims.com and forhers.com.
In July of 2021, hims & hers acquired Apostrophe, a healthcare technology platform reimagining what dermatology should look like in the 21st century. Apostrophe is the only company to combine a nationwide network of dermatologists and a prescription compounding facility to provide world-class dermatology care at a fraction of the cost or hassle of the traditional healthcare system. Apostrophe is a fully autonomous startup brand under H&H, now with the resources of a multi-billion dollar public company to scale our revolutionary offerings to the stratosphere, and they're hiring, too! Check out their open roles here.